Electrochemotherapy in the treatment of metastatic malignant melanoma: a prospective cohort study by InspECT

British Journal of Dermatology

Volumn 176, Issue 6, 2017, Pages 1475-1485

  Kunte, C ^a   Letule V ^a   Gehl, J ^b   Dahlstroem, K ^b   Curatolo, P ^c   Rotunno, R ^c   Muir, T ^d   Occhini, A ^e   Bertino, G ^e   Powell, B ^f   Saxinger, W ^g   Lechner, G ^g   Liew, S H ^h   Pritchard Jones, R ^h   Rutkowski, P ⁱ   Zdzienicki, M ⁱ   Mowatt, D ^j   Sykes, A J ^k   Orlando, A ^l   Mitsala, G ^l   Rossi, C R ^m,n   Campana, L ^m,n   Brizio, M ^o   de Terlizzi, F ^p   Quaglino, P ^o   Odili, J ^f   more..

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^e UNIVERSITY OF PAVIA   (Italy)

^f ST GEORGE S HOSPITAL   (United Kingdom)

^g Klinikum Wels Grieskirchen GmbH   (Austria)

^h WHISTON HOSPITAL   (United Kingdom)

ⁱ INSTITUTE OF ONCOLOGY   (Poland)

^j Department of Plastic Surgery ^*  (United Kingdom)

^k CHRISTIE HOSPITAL   (United Kingdom)

^l SOUTHMEAD HOSPITAL   (United Kingdom)

^m VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

ⁿ UNIVERSITY OF PADOVA   (Italy)

^o UNIVERSITY OF TURIN   (Italy)

^p IGEA SPA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; BLEOMYCIN;

ADULT; AGED; ARTICLE; CANCER CENTER; CANCER SIZE; CANCER SURVIVAL; COHORT ANALYSIS; DATA BASE; DEEP SEDATION; DISEASE FREE SURVIVAL; ELECTROCHEMOTHERAPY; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; GENERAL ANESTHESIA; HUMAN; LOCAL ANESTHESIA; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; METASTATIC MELANOMA; MIDDLE AGED; NAUSEA; OVERALL SURVIVAL; PAIN INTENSITY; PAIN MEASUREMENT; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; TREATMENT RESPONSE; VERY ELDERLY; ANESTHESIA; CLINICAL TRIAL; DEVICES; DISEASE EXACERBATION; ELECTRODE; KAPLAN MEIER METHOD; MELANOMA; METASTASIS; MORTALITY; MULTICENTER STUDY; PAIN; PATHOLOGY; PROCEDURES; SKIN TUMOR; TREATMENT OUTCOME; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; ANESTHESIA; DISEASE PROGRESSION; ELECTROCHEMOTHERAPY; ELECTRODES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MELANOMA; NEOPLASM METASTASIS; PAIN; PAIN MEASUREMENT; PROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 85018260390     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.15340     Document Type: Article

References (45)

1. Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases in patients with metastatic carcinoma: a retrospective study of 4020 patients. J Am Acad Dermatol 1993; 29:228–36.
2. Matthiessen LW, Chalmers RL, Sainsbury DC et al. Management of cutaneous metastases using electrochemotherapy. Acta Oncol 2011; 50:621–9.
3. Kahler KC, Egberts F, Gutzmer R. Palliative treatment of skin metastases in dermato-oncology. J Dtsch Dermatol Ges 2013; 11:1041–5.
4. Testori A, Rutkowski P, Marsden J et al. Surgery and radiotherapy in the treatment of cutaneous melanoma. Ann Oncol 2009; 20 (Suppl. 6):vi22–9.
5. National Institute for Health and Care Excellence. Electrochemotherapy for metastases in the skin from tumours of non-skin origin and melanoma. Available at: https://www.nice.org.uk/guidance/ipg446 (last accessed 14 March 2017).
6. Belehradek M, Domenge C, Luboinski B et al. Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer 1993; 72:3694–700.
7. Reinhold U. Electrochemotherapy of skin tumours. Hautarzt 2011; 62:549–58 (in German).
8. Mali B, Jarm T, Snoj M et al. Antitumor effectiveness of electrochemotherapy: a systematic review and meta-analysis. Eur J Surg Oncol 2013; 39:4–16.
9. Gehl J, Skovsgaard T, Mir LM. Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim Biophys Acta 2002; 1569:51–8.
10. Markelc B, Sersa G, Cemazar M. Differential mechanisms associated with vascular disrupting action of electrochemotherapy: intravital microscopy on the level of single normal and tumor blood vessels. PLoS One 2013; 8:e59557.
11. Sersa G, Cemazar M, Miklavcic D et al. Tumor blood flow modifying effect of electrochemotherapy with bleomycin. Anticancer Res 1999; 19:4017–22.
12. Sersa G, Cemazar M, Snoj M. Electrochemotherapy of tumours. Curr Oncol 2009; 16:34–5.
13. Kis E, Olah J, Ocsai H et al. Electrochemotherapy of cutaneous metastases of melanoma – a case series study and systematic review of the evidence. Dermatol Surg 2011; 37:816–24.
14. Brizio M, Fava P, Astrua C et al. Complete regression of melanoma skin metastases after electrochemotherapy plus ipilimumab treatment: an unusual clinical presentation. Eur J Dermatol 2015; 25:271–2.
15. Campana LG, Mocellin S, Basso M et al. Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients. Ann Surg Oncol 2009; 16:191–9.
16. Campana LG, Testori A, Mozzillo N et al. Treatment of metastatic melanoma with electrochemotherapy. J Surg Oncol 2014; 109:301–7.
17. Campana LG, Valpione S, Mocellin S et al. Electrochemotherapy for disseminated superficial metastases from malignant melanoma. Br J Surg 2012; 99:821–30.
18. Caracò C, Mozzillo N, Marone U et al. Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis. BMC Cancer 2013; 13:564.
19. Gehl J, Geertsen PF. Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy. Melanoma Res 2000; 10:585–9.
20. Heller R, Jaroszeski MJ, Reintgen DS et al. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer 1998; 83:148–57.
21. Marty M, Sersa G, Garbay JR et al. Electrochemotherapy – an easy, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures of Electrochemotherapy) study. Eur J Cancer Suppl 2006; 4:3–13.
22. Matthiessen LW, Johannesen HH, Hendel HW et al. Electrochemotherapy for large cutaneous recurrence of breast cancer: a phase II clinical trial. Acta Oncol 2012; 51:713–21.
23. Mir LM, Gehl J, Sersa G et al. Standard operating procedures of the electrochemotherapy: instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses by the Cliniporator™ by means of invasive or non-invasive electrodes. Eur J Cancer Suppl 2006; 4:14–25.
24. Quaglino P, Mortera C, Osella-Abate S et al. Electrochemotherapy with intravenous bleomycin in the local treatment of skin melanoma metastases. Ann Surg Oncol 2008; 15:2215–22.
25. Queirolo P, Marincola F, Spagnolo F. Electrochemotherapy for the management of melanoma skin metastasis: a review of the literature and possible combinations with immunotherapy. Arch Dermatol Res 2014; 306:521–6.
26. Snoj M, Cemazar M, Srnovrsnik T et al. Limb sparing treatment of bleeding melanoma recurrence by electrochemotherapy. Tumori 2009; 95:398–402.
27. Solari N, Spagnolo F, Ponte E et al. Electrochemotherapy for the management of cutaneous and subcutaneous metastasis: a series of 39 patients treated with palliative intent. J Surg Oncol 2014; 109:270–4.
28. Tijink BM, De Bree R, Van Dongen GA et al. How we do it: chemo-electroporation in the head and neck for otherwise untreatable patients. Clin Otolaryngol 2006; 31:447–51.
29. Tozon N, Pavlin D, Sersa G et al. Electrochemotherapy with intravenous bleomycin injection: an observational study in superficial squamous cell carcinoma in cats. J Feline Med Surg 2014; 16:291–9.
30. Valpione S, Campana LG, Pigozzo J et al. Consolidation electrochemotherapy with bleomycin in metastatic melanoma during treatment with dabrafenib. Radiol Oncol 2015; 49:71–4.
31. Spratt DE, Gordon Spratt EA, Wu S et al. Efficacy of skin-directed therapy for cutaneous metastases from advanced cancer: a meta-analysis. J Clin Oncol 2014; 32:3144–55.
32. Quaglino P, Matthiessen LW, Curatolo P et al. Predicting patients at risk for pain associated with electrochemotherapy. Acta Oncol 2015; 54:298–306.
33. Pawlik TM, Ross MI, Thompson JF et al. The risk of in-transit melanoma metastasis depends on tumor biology and not the surgical approach to regional lymph nodes. J Clin Oncol 2005; 23:4588–90.
34. Andersen MH, Gehl J, Reker S et al. Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administration. Semin Cancer Biol 2003; 13:449–59.
35. Daud AI, DeConti RC, Andrews S et al. Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 2008; 26:5896–903.
36. Testori A, Rossi CR, Tosti G. Utility of electrochemotherapy in melanoma treatment. Curr Opin Oncol 2012; 24:155–61.
37. Larkin JO, Collins CG, Aarons S et al. Electrochemotherapy: aspects of preclinical development and early clinical experience. Ann Surg 2007; 245:469–79.
38. Mali B, Miklavcic D, Campana LG et al. Tumor size and effectiveness of electrochemotherapy. Radiol Oncol 2013; 47:32–41.
39. Calvet CY, Famin D, Andre FM et al. Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells. Oncoimmunology 2014; 3:e28131.
40. Bentzen SM. Preventing or reducing late side-effects of radiation therapy: radiobiology meets molecular pathology. Nat Rev Cancer 2006; 6:702–13.
41. Brush J, Lipnick SL, Phillips T et al. Molecular mechanisms of late normal tissue injury. Semin Radiat Oncol 2007; 17:121–30.
42. Kranjc S, Tevz G, Kamensek U et al. Radiosensitizing effect of electrochemotherapy in a fractionated radiation regimen in radiosensitive murine sarcoma and radioresistant adenocarcinoma tumor model. Radiat Res 2009; 172:677–85.
43. Raeisi E, Aghamiri SM, Bandi A et al. The antitumor efficiency of combined electrochemotherapy and single dose irradiation on a breast cancer tumor model. Radiol Oncol 2012; 46:226–32.
44. Sersa G, Kranjc S, Cemazar M. Improvement of combined modality therapy with cisplatin and radiation using electroporation of tumors. Int J Radiat Oncol Biol Phys 2000; 46:1037–41.
45. Todorovic V, Sersa G, Mlakar V et al. Metastatic potential of melanoma cells is not affected by electrochemotherapy. Melanoma Res 2011; 21:196–205.